Roman Shimanovich

In silico prediction of pharmaceutical degradation pathways: a benchmarking study.

Karen M. Alsante, Steven W Baertschi, Mark H Kleinman, 2014, Molecular pharmaceutics.

Corrigendum to “Discovery and optimization of potent and selective triazolopyridazine series of c-Met inhibitors” [Bioorg. Med. Chem. Lett. 19 (2009) 6307]

Kavita Shah, April Chen, David Bauer, 2010 .

Sulfonamides as Selective NaV1.7 Inhibitors: Optimizing Potency, Pharmacokinetics, and Metabolic Properties to Obtain Atropisomeric Quinolinone (AM-0466) that Affords Robust in Vivo Activity.

Roman Shimanovich, Angel Guzman-Perez, R. Fremeau, 2017, Journal of medicinal chemistry.